<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39355395</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1949-8470</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>World journal of radiology</Title><ISOAbbreviation>World J Radiol</ISOAbbreviation></Journal><ArticleTitle>Myelin oligodendrocyte glycoprotein-associated transverse myelitis after SARS-CoV-2 infection: A case report.</ArticleTitle><Pagination><StartPage>446</StartPage><EndPage>452</EndPage><MedlinePgn>446-452</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4329/wjr.v16.i9.446</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cases of myelin oligodendrocyte glycoprotein (MOG) antibody-related disease have a history of coronavirus disease 2019 infection or its vaccination before disease onset. Severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection has been considered to be a trigger of central nervous system autoimmune diseases.</AbstractText><AbstractText Label="CASE SUMMARY" NlmCategory="METHODS">Here we report a 20-year male with MOG-associated transverse myelitis after a SARS-CoV-2 infection. The patient received a near-complete recovery after standard immunological treatments.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Attention should be paid to the evaluation of typical or atypical neurological symptoms that may be triggered by SARS-CoV-2 infection.</AbstractText><CopyrightInformation>©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Jian-Rong</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Shenzhen Xinhua Hospital, Shenzhen 518000, Guangdong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Jun-Lei</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518000, Guangdong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Zhi-Jian</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Kai-Hua</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Bi-Hua</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Sixth People's Hospital of Foshan Nanhai District, Foshan 528000, Guangdong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xu-Hui</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China. xuhuichen@pkuszh.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhi-Gang</ForeName><Initials>ZG</Initials><AffiliationInfo><Affiliation>Laboratory of Functional Chemistry and Nutrition of Food, Northwest A&amp;F University, Yangling 712100, Shaanxi Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Radiol</MedlineTA><NlmUniqueID>101538184</NlmUniqueID><ISSNLinking>1949-8470</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Case report</Keyword><Keyword MajorTopicYN="N">Myelin oligodendrocyte glycoprotein antibody-associated disease</Keyword><Keyword MajorTopicYN="N">Myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Conflict-of-interest statement: The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>4</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39355395</ArticleId><ArticleId IdType="pmc">PMC11440270</ArticleId><ArticleId IdType="doi">10.4329/wjr.v16.i9.446</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ariño H, Heartshorne R, Michael BD, Nicholson TR, Vincent A, Pollak TA, Vogrig A. Neuroimmune disorders in COVID-19. J Neurol. 2022;269:2827–2839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9120100</ArticleId><ArticleId IdType="pubmed">35353232</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham-Dinh D, Mattei MG, Nussbaum JL, Roussel G, Pontarotti P, Roeckel N, Mather IH, Artzt K, Lindahl KF, Dautigny A. Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc Natl Acad Sci U S A. 1993;90:7990–7994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC47273</ArticleId><ArticleId IdType="pubmed">8367453</ArticleId></ArticleIdList></Reference><Reference><Citation>Marignier R, Hacohen Y, Cobo-Calvo A, Pröbstel AK, Aktas O, Alexopoulos H, Amato MP, Asgari N, Banwell B, Bennett J, Brilot F, Capobianco M, Chitnis T, Ciccarelli O, Deiva K, De Sèze J, Fujihara K, Jacob A, Kim HJ, Kleiter I, Lassmann H, Leite MI, Linington C, Meinl E, Palace J, Paul F, Petzold A, Pittock S, Reindl M, Sato DK, Selmaj K, Siva A, Stankoff B, Tintore M, Traboulsee A, Waters P, Waubant E, Weinshenker B, Derfuss T, Vukusic S, Hemmer B. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021;20:762–772.</Citation><ArticleIdList><ArticleId IdType="pubmed">34418402</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382:1199–1207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020;382:2268–2270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agrò FE. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288:192–206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267177</ArticleId><ArticleId IdType="pubmed">32348588</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S. Acute myelitis after SARS-CoV-2 infection: a case report. Preprint from: medRxiv 2020.</Citation></Reference><Reference><Citation>Mariotto S, Carta S, Dinoto A, Lippi G, Salvagno GL, Masin L, Alberti D, Marignier R, Ferrari S. Is there a correlation between MOG-associated disorder and SARS-CoV-2 infection? Eur J Neurol. 2022;29:1855–1858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111815</ArticleId><ArticleId IdType="pubmed">35224824</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnsson M, Asztely F, Hejnebo S, Axelsson M, Malmeström C, Olausson T, Lycke J. SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder. Ann Clin Transl Neurol. 2022;9:1296–1301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349599</ArticleId><ArticleId IdType="pubmed">35713508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambe J, McGinley MP, Moss BP, Mao-Draayer Y, Kassa R, Ciotti JR, Mariotto S, Kunchok A. Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series. J Neuroimmunol. 2022;370:577933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9279254</ArticleId><ArticleId IdType="pubmed">35878436</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarma D, Bilello LA. A Case Report of Acute Transverse Myelitis Following Novel Coronavirus Infection. Clin Pract Cases Emerg Med. 2020;4:321–323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434287</ArticleId><ArticleId IdType="pubmed">32926676</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotoca J, Rodríguez-Álvarez Y. COVID-19-associated acute necrotizing myelitis. Neurol Neuroimmunol Neuroinflamm. 2020;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7309521</ArticleId><ArticleId IdType="pubmed">32522767</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Z, Sun S, Xiao S, Chen G, Chen P, Yang Z, Tang X, Huang L, Wang Y. COVID-19 is associated with changes in brain function and structure: A multimodal meta-analysis of neuroimaging studies. Neurosci Biobehav Rev. 2024;164:105792.</Citation><ArticleIdList><ArticleId IdType="pubmed">38969310</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L, Wang X. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215–220.</Citation><ArticleIdList><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444–1448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683–690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82:7264–7275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Zhang M, Wang J, Gao J. Sars-Cov-2: Underestimated damage to nervous system. Travel Med Infect Dis. 2020;36:101642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269702</ArticleId><ArticleId IdType="pubmed">32220634</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>McCray PB Jr, Pewe L, Wohlford-Lenane C, Hickey M, Manzel L, Shi L, Netland J, Jia HP, Halabi C, Sigmund CD, Meyerholz DK, Kirby P, Look DC, Perlman S. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007;81:813–821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1797474</ArticleId><ArticleId IdType="pubmed">17079315</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, Bieber N, Haas J, Wildemann B. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature. J Neurol. 2022;269:5198–5212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9219396</ArticleId><ArticleId IdType="pubmed">35737110</ArticleId></ArticleIdList></Reference><Reference><Citation>Sechi E, Buciuc M, Flanagan EP, Pittock SJ, Banks SA, Lopez-Chiriboga AS, Bhatti MT, Chen JJ. Variability of cerebrospinal fluid findings by attack phenotype in myelin oligodendrocyte glycoprotein-IgG-associated disorder. Mult Scler Relat Disord. 2021;47:102638.</Citation><ArticleIdList><ArticleId IdType="pubmed">33276239</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler M, Tamborska A, Wood GK, Ellul M, Thomas RH, Galea I, Pett S, Singh B, Solomon T, Pollak TA, Michael BD, Nicholson TR. Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder. J Neurol Neurosurg Psychiatry. 2021;92:1144–1151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7614639</ArticleId><ArticleId IdType="pubmed">34362855</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>